Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 4/2014

01-04-2014 | Letter to the Editor

Therapy-related acute myeloid leukemia in a patient with chronic lymphocytic leukemia treated with rituximab–bendamustine

Authors: Ricardo García-Muñoz, Diana K. García, Verónica Roldán-Galiacho, Miriam Merchante-Andreu, Andrea Campeny-Najara, Pilar Rabasa

Published in: Annals of Hematology | Issue 4/2014

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
Fischer K, Cramper P, Busch R, Böttcher S, Bahlo J, Schubert J et al (2012) Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukaemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukaemia Study Group. J Clin Oncol 30:3209–3216PubMedCrossRef
2.
Rummel MJ, Tenzer A, Niederle N et al. (2010) No elevated rates of treatment-related myelodysplastic syndromes and second solid tumors following therapy with bendamustine compared with other anti-lymphoma regimes for low-grade non-hodgkin’s lymphoma. Abstract 3090. ASH, Orlando, FL, December 4–7
3.
Rummel MJ, Niederle N, Maschmeyer G et al (2013) Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 6736:61763–2
4.
Mauritzon N, Albin M, Rylander L et al (2002) Pooled analysis of clinical and cytogenetic features in treatment-related and the novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001. Leukemia 16:2366–2378CrossRef
5.
Hosoda T, Yokoyama A, Yoneda M, Yamamoto R, Ohashi K, Kaggo T et al (2012) Bendamustine can severely impair T cell immunity against cytomegalovirus. Leuk Lymphoma 54:1327–1328PubMedCrossRef
6.
Dolen Y, Esendagli G (2013) Myeloid leukemia cells with a B7-2+ subpopulation provoke Th cell responses and become immune-suppressive through the modulation of B7 ligands. Eur J Immunol 43:747–757PubMedCrossRef
Metadata
Title
Therapy-related acute myeloid leukemia in a patient with chronic lymphocytic leukemia treated with rituximab–bendamustine
Authors
Ricardo García-Muñoz
Diana K. García
Verónica Roldán-Galiacho
Miriam Merchante-Andreu
Andrea Campeny-Najara
Pilar Rabasa
Publication date
01-04-2014
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 4/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1844-8

Other articles of this Issue 4/2014

Annals of Hematology 4/2014 Go to the issue

Original Article

Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens

Letter to the Editor

Severe immune thrombocytopenia secondary to Waldenström's macroglobulinemia with anti-GPIb/IX monoclonal IgM antibody

Letter to the Editor

Improvement in hereditary hemorrhagic telangiectasia after treatment with the phosphoinositide 3-kinase inhibitor BKM120

Original Article

Iron-dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses

Original Article

Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients

Original Article

A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits